Healthcare
Healthcare
Bottomline: True North-controlled Integrace's growth slows despite M&A; margin shrinks
Integrace Pvt Ltd, the pharmaceutical company that counts Indian private equity firm True North and Singapore state investment firm Temasek as ......
Healthcare
Exclusive: Kerala hospital in talks with local, global PE firms for stake sale
Baby Memorial Hospital, one of the largest hospitals in Kerala, is in talks with several private equity firms, including global ......
Healthcare
Medical devices firm Tynor plans fundraise, PE backer to exit
Medical devices maker Tynor Orthotics Pvt Ltd is planning to start a fresh fundraise process in a move that may ......
Healthcare
Advent may rope in new investor for Bharat Serums with neat valuation markup
Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......
Healthcare
TPG-backed AHH's Vishal Bali on acquisitions, margins and consolidation in IVF
Asia Healthcare Holdings (AHH), the healthcare platform of private equity firm TPG, operates Motherhood Hospitals and Nova Fertility Clinics in ......
Healthcare
Exclusive: General Atlantic, Tata PE fund eye hospital chain operator
US-based private equity major General Atlantic and an Indian mid-market PE fund managed by Tata Capital are evaluating the possibility ......
Healthcare
Exclusive: Investcorp-backed Clove in talks to buy VC-backed dental chain
Dental care chain Clove Dental is evaluating a proposal to pick up a controlling stake in a smaller peer to ......
Healthcare
Quadria Capital to sign large cheque for eyecare chain Maxivision
Healthcare-focused private equity investor Quadria Capital will invest up to Rs 1,300 crore (around $158 million) in GSK Velu-led eyecare ......
Healthcare
Pharmeasy eyes $304 mn in funding from Manipal Group, existing investors
Omnichannel pharmacy chain Pharmeasy plans to raise ₹2,500 crore ($304 million) to retire the senior debt it had raised from ......
Healthcare
GIC-backed Syngene inks $88-mn deal to buy Stelis Biopharma's unit
Syngene International Ltd, a drug research company backed by Singapore sovereign wealth fund GIC, is set to acquire Stelis Biopharma’s manufacturing unit in Bengaluru for ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News